Literature DB >> 26545404

Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.

Xuezheng Sun1, Hazel B Nichols2, Chiu-Kit Tse1, Mary B Bell3, Whitney R Robinson1, Mark E Sherman4, Andrew F Olshan2, Melissa A Troester5.   

Abstract

BACKGROUND: Parity and time since last birth influence breast cancer risk and vary by intrinsic tumor subtype, but the independent effects of these factors on prognosis have received limited attention.
METHODS: Study participants were 1,140 invasive breast cancer patients from phases I and II of the population-based Carolina Breast Cancer Study, with tissue blocks available for subtyping using immunohistochemical markers. Breast cancer risk factors, including pregnancy history, were collected via in-person interviews administered shortly after diagnosis. Vital status was determined using the National Death Index. The association of parity and birth recency with breast cancer-specific and overall survival was assessed using Cox proportional hazards models.
RESULTS: During follow-up (median = 13.5 years), 450 patients died, 61% due to breast cancer (n = 276). High parity (3+ births) and recent birth (<5 years before diagnosis) were positively associated with breast cancer-specific mortality, independent of age, race, and selected socioeconomic factors [parity, reference = nulliparous, adjusted HR = 1.76; 95% confidence interval (CI) = 1.13-2.73; birth recency, reference = 10+ years, adjusted HR = 1.29; 95% CI, 0.79-2.11]. The associations were stronger among patients with luminal tumors and those surviving longer than 5 years.
CONCLUSIONS: Parity and recent birth are associated with worse survival among breast cancer patients, particularly among luminal breast cancers and long-term survivors. IMPACT: The biologic effects of parity and birth recency may extend from etiology to tumor promotion and progression. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26545404      PMCID: PMC4727837          DOI: 10.1158/1055-9965.EPI-15-0864

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  52 in total

Review 1.  Estimating the risk of breast cancer in relation to the interval since last term pregnancy.

Authors:  P Cummings; N S Weiss; B McKnight; J L Stanford
Journal:  Epidemiology       Date:  1997-09       Impact factor: 4.822

2.  Immortal person-time in studies of cancer outcomes.

Authors:  Timothy L Lash; Stephen R Cole
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

3.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Authors:  Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

4.  Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats.

Authors:  Takashi Yuri; Yen-Chang Lai; Sayaka Kanematsu; Maki Kuwata; Katsuhiko Yoshizawa; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

5.  Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.

Authors:  Aleix Prat; Maggie Chon U Cheang; Miguel Martín; Joel S Parker; Eva Carrasco; Rosalía Caballero; Scott Tyldesley; Karen Gelmon; Philip S Bernard; Torsten O Nielsen; Charles M Perou
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

6.  Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.

Authors:  Traci R Lyons; Jenean O'Brien; Virginia F Borges; Matthew W Conklin; Patricia J Keely; Kevin W Eliceiri; Andriy Marusyk; Aik-Choon Tan; Pepper Schedin
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

Review 7.  Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors:  Hatem A Azim; Luigi Santoro; William Russell-Edu; George Pentheroudakis; Nicholas Pavlidis; Fedro A Peccatori
Journal:  Cancer Treat Rev       Date:  2012-07-09       Impact factor: 12.111

8.  Effect of pregnancy on prognosis for young women with breast cancer.

Authors:  V F Guinee; H Olsson; T Möller; K R Hess; S H Taylor; T Fahey; J V Gladikov; J W van den Blink; F Bonichon; S Dische
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

9.  Reproductive history and prognosis in patients with operable breast cancer.

Authors:  S Korzeniowski; T Dyba
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

10.  PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

Authors:  Roy R L Bastien; Álvaro Rodríguez-Lescure; Mark T W Ebbert; Aleix Prat; Blanca Munárriz; Leslie Rowe; Patricia Miller; Manuel Ruiz-Borrego; Daniel Anderson; Bradley Lyons; Isabel Álvarez; Tracy Dowell; David Wall; Miguel Ángel Seguí; Lee Barley; Kenneth M Boucher; Emilio Alba; Lisa Pappas; Carole A Davis; Ignacio Aranda; Christiane Fauron; Inge J Stijleman; José Palacios; Antonio Antón; Eva Carrasco; Rosalía Caballero; Matthew J Ellis; Torsten O Nielsen; Charles M Perou; Mark Astill; Philip S Bernard; Miguel Martín
Journal:  BMC Med Genomics       Date:  2012-10-04       Impact factor: 3.063

View more
  10 in total

Review 1.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

2.  Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.

Authors:  Sanah N Vohra; Andrea Walens; Alina M Hamilton; Mark E Sherman; Pepper Schedin; Hazel B Nichols; Katherine E Reeder-Hayes; Andrew F Olshan; Michael I Love; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-03-01       Impact factor: 4.090

3.  Overall survival is the lowest among young women with postpartum breast cancer.

Authors:  Elena Shagisultanova; Dexiang Gao; Eryn Callihan; Hannah J Parris; Betsy Risendal; Lisa M Hines; Martha L Slattery; Kathy Baumgartner; Pepper Schedin; Esther M John; Virginia F Borges
Journal:  Eur J Cancer       Date:  2022-05-04       Impact factor: 10.002

4.  Integrating biology and access to care in addressing breast cancer disparities: 25 years' research experience in the Carolina Breast Cancer Study.

Authors:  Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester
Journal:  Curr Breast Cancer Rep       Date:  2020-05-14

5.  Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Authors:  Anna Morra; Audrey Y Jung; Marjanka K Schmidt; Jenny Chang-Claude; Sabine Behrens; Renske Keeman; Thomas U Ahearn; Hoda Anton-Culver; Volker Arndt; Annelie Augustinsson; Päivi K Auvinen; Laura E Beane Freeman; Heiko Becher; Matthias W Beckmann; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Hermann Brenner; Ignacio Briceno; Sara Y Brucker; Nicola J Camp; Daniele Campa; Federico Canzian; Jose E Castelao; Stephen J Chanock; Ji-Yeob Choi; Christine L Clarke; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Thilo Dörk; Alison M Dunning; Miriam Dwek; Douglas F Easton; Diana M Eccles; Kathleen M Egan; D Gareth Evans; Peter A Fasching; Henrik Flyger; Manuela Gago-Dominguez; Susan M Gapstur; José A García-Sáenz; Mia M Gaudet; Graham G Giles; Mervi Grip; Pascal Guénel; Christopher A Haiman; Niclas Håkansson; Per Hall; Ute Hamann; Sileny N Han; Steven N Hart; Mikael Hartman; Jane S Heyworth; Reiner Hoppe; John L Hopper; David J Hunter; Hidemi Ito; Agnes Jager; Milena Jakimovska; Anna Jakubowska; Wolfgang Janni; Rudolf Kaaks; Daehee Kang; Pooja Middha Kapoor; Cari M Kitahara; Stella Koutros; Peter Kraft; Vessela N Kristensen; James V Lacey; Diether Lambrechts; Loic Le Marchand; Jingmei Li; Annika Lindblom; Jan Lubiński; Michael Lush; Arto Mannermaa; Mehdi Manoochehri; Sara Margolin; Shivaani Mariapun; Keitaro Matsuo; Dimitrios Mavroudis; Roger L Milne; Taru A Muranen; William G Newman; Dong-Young Noh; Børge G Nordestgaard; Nadia Obi; Andrew F Olshan; Håkan Olsson; Tjoung-Won Park-Simon; Christos Petridis; Paul D P Pharoah; Dijana Plaseska-Karanfilska; Nadege Presneau; Muhammad U Rashid; Gad Rennert; Hedy S Rennert; Valerie Rhenius; Atocha Romero; Emmanouil Saloustros; Elinor J Sawyer; Andreas Schneeweiss; Lukas Schwentner; Christopher Scott; Mitul Shah; Chen-Yang Shen; Xiao-Ou Shu; Melissa C Southey; Daniel O Stram; Rulla M Tamimi; William Tapper; Rob A E M Tollenaar; Ian Tomlinson; Diana Torres; Melissa A Troester; Thérèse Truong; Celine M Vachon; Qin Wang; Sophia S Wang; Justin A Williams; Robert Winqvist; Alicja Wolk; Anna H Wu; Keun-Young Yoo; Jyh-Cherng Yu; Wei Zheng; Argyrios Ziogas; Xiaohong R Yang; A Heather Eliassen; Michelle D Holmes; Montserrat García-Closas; Soo Hwang Teo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-01-26       Impact factor: 4.090

Review 6.  Human Chorionic Gonadotropin and Breast Cancer.

Authors:  Susanne Schüler-Toprak; Oliver Treeck; Olaf Ortmann
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

7.  The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations.

Authors:  Mary Beth Terry; Yuyan Liao; Karin Kast; Antonis C Antoniou; Jasmine A McDonald; Thea M Mooij; Christoph Engel; Catherine Nogues; Bruno Buecher; Véronique Mari; Jessica Moretta-Serra; Laurence Gladieff; Elisabeth Luporsi; Daniel Barrowdale; Debra Frost; Alex Henderson; Carole Brewer; D Gareth Evans; Diana Eccles; Jackie Cook; Kai-Ren Ong; Louise Izatt; Munaza Ahmed; Patrick J Morrison; Charlotte J Dommering; Jan C Oosterwijk; Margreet G E M Ausems; Mieke Kriege; Saundra S Buys; Irene L Andrulis; Esther M John; Mary Daly; Michael Friedlander; Sue Anne McLachlan; Ana Osorio; Trinidad Caldes; Anna Jakubowska; Jacques Simard; Christian F Singer; Yen Tan; Edith Olah; Marie Navratilova; Lenka Foretova; Anne-Marie Gerdes; Marie-José Roos-Blom; Brita Arver; Håkan Olsson; Rita K Schmutzler; John L Hopper; Flora E van Leeuwen; David Goldgar; Roger L Milne; Douglas F Easton; Matti A Rookus; Nadine Andrieu
Journal:  JNCI Cancer Spectr       Date:  2019-03-08

8.  Associations of reproductive factors with breast cancer prognosis and the modifying effects of menopausal status.

Authors:  Jia-Yi Zhang; Mei-Xia Wang; Xiang Wang; Yue-Lin Li; Zhuo-Zhi Liang; Ying Lin; Qiang Liu; Xiao-Ming Xie; Lu-Ying Tang; Ze-Fang Ren
Journal:  Cancer Med       Date:  2019-11-14       Impact factor: 4.452

9.  The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer.

Authors:  Yasmin Korzets; Orly Yariv; Raz Mutai; Assaf Moore; Tzippy Shochat; Rinat Yerushalmi; Hadar Goldvaser
Journal:  Discov Oncol       Date:  2021-08-17

10.  Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.

Authors:  Jonine D Figueroa; Brittny C Davis Lynn; Lawrence Edusei; Nicholas Titiloye; Ernest Adjei; Joe-Nat Clegg-Lamptey; Joel Yarney; Beatrice Wiafe-Addai; Baffour Awuah; Maire A Duggan; Seth Wiafe; Kofi Nyarko; Francis Aitpillah; Daniel Ansong; Stephen M Hewitt; Thomas Ahearn; Montserrat Garcia-Closas; Louise A Brinton
Journal:  Int J Cancer       Date:  2020-03-13       Impact factor: 7.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.